Neuroscientific Biopharmaceuticals (ASX:NSB) EPS (Basic): A$-0.02 (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Neuroscientific Biopharmaceuticals EPS (Basic)?

Neuroscientific Biopharmaceuticals ASX:NSB EPS (Basic) is A$-0.02 as of Dec. 2025. The stock has 1 warning sign investors should review.

Neuroscientific Biopharmaceuticals's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was A$-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.02.

Neuroscientific Biopharmaceuticals's EPS (Diluted) for the six months ended in Dec. 2025 was A$-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.02.

Neuroscientific Biopharmaceuticals's EPS without NRI for the six months ended in Dec. 2025 was A$-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was -0.02.

During the past 12 months, Neuroscientific Biopharmaceuticals's average EPS without NRIGrowth Rate was -287.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was 43.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, Neuroscientific Biopharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 43.70% per year. The lowest was -47.00% per year. And the median was 42.60% per year.

Neuroscientific Biopharmaceuticals  (ASX:NSB) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Neuroscientific Biopharmaceuticals EPS (Basic) Related Terms

Neuroscientific Biopharmaceuticals EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Neuroscientific Biopharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuroscientific Biopharmaceuticals EPS (Basic) Chart

Neuroscientific Biopharmaceuticals Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EPS (Basic)
Get a 7-Day Free Trial -0.02 -0.07 -0.01 0.00 -0.01

Neuroscientific Biopharmaceuticals Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 0.01 -0.00 -0.01 -0.01

Neuroscientific Biopharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Neuroscientific Biopharmaceuticals's Basic EPS for the fiscal year that ended in Jun. 2025 is calculated as

Basic EPS (A: Jun. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.846-0)/146.665
=-0.01

Neuroscientific Biopharmaceuticals's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.699-0)/332.576
=-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of A$-0.02 mean?
Neuroscientific Biopharmaceuticals (ASX:NSB) has a EPS (Basic) of A$-0.02 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Neuroscientific Biopharmaceuticals and its competitors.
Is Neuroscientific Biopharmaceuticals' EPS (Basic) too high?
Neuroscientific Biopharmaceuticals' current EPS (Basic) is A$-0.02.
How does Neuroscientific Biopharmaceuticals' EPS (Basic) compare to VRTX and REGN?
Neuroscientific Biopharmaceuticals' EPS (Basic) of A$-0.02 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Neuroscientific Biopharmaceuticals and its competitors. Neuroscientific Biopharmaceuticals's current EPS (Basic) is A$-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuroscientific Biopharmaceuticals stock overvalued right now?
Neuroscientific Biopharmaceuticals (ASX:NSB) has a current EPS (Basic) of A$-0.02. The current EPS (Basic) is A$-0.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Neuroscientific Biopharmaceuticals (ASX:NSB), the current EPS (Basic) is A$-0.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neuroscientific Biopharmaceuticals Business Description

Address 216 Street Georges Terrace, Level 4, Perth, WA, AUS, 6000
Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and treatments for neurodegenerative diseases through preclinical studies of patented technologies.